StockNews.com Upgrades Nu Skin Enterprises (NYSE:NUS) to Buy

Nu Skin Enterprises (NYSE:NUS) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday.

Several other research analysts have also recently weighed in on the stock. Citigroup dropped their price objective on shares of Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating for the company in a research report on Friday, August 9th. DA Davidson dropped their target price on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.50.

Nu Skin Enterprises Trading Down 4.2 %

Shares of NUS opened at $8.00 on Friday. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The stock has a 50 day simple moving average of $10.04 and a 200-day simple moving average of $11.79. Nu Skin Enterprises has a 1 year low of $8.00 and a 1 year high of $24.38. The stock has a market cap of $397.34 million, a PE ratio of -133.33 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. The company had revenue of $439.10 million during the quarter, compared to analysts’ expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. Nu Skin Enterprises’s quarterly revenue was down 12.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 earnings per share. On average, sell-side analysts predict that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Nu Skin Enterprises

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NUS. New York State Common Retirement Fund grew its holdings in Nu Skin Enterprises by 11.8% during the fourth quarter. New York State Common Retirement Fund now owns 41,000 shares of the company’s stock valued at $796,000 after purchasing an additional 4,334 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 17.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock valued at $22,482,000 after buying an additional 173,193 shares during the period. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at $227,000. Janney Montgomery Scott LLC acquired a new stake in Nu Skin Enterprises during the 4th quarter worth $481,000. Finally, Kingsview Wealth Management LLC lifted its holdings in Nu Skin Enterprises by 39.0% during the fourth quarter. Kingsview Wealth Management LLC now owns 109,652 shares of the company’s stock worth $2,129,000 after acquiring an additional 30,792 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.